P4HB Absorbable Surgical Meshes for Prolonged Strength Retention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical textiles and fibers, such as surgical meshes and sutures, face challenges with short-term strength retention, leading to complications like adhesions, infection risks, and limited suitability for pediatric patients, while synthetic absorbable materials are limited by inflammatory responses and disease transmission concerns.
Innovation Solution
Development of absorbable polyester fibers and meshes derived from biocompatible copolymers or homopolymers of 4-hydroxybutyrate, which exhibit prolonged strength retention, anti-adhesion properties, and reduced inflammatory reactions, suitable for use in various surgical procedures including hernia repair, cardiovascular applications, and pediatric populations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If synthetic absorbable materials are used for surgical meshes and sutures, then absorption capability is achieved, but inflammatory responses and disease transmission risks occur
Solution Approach 1:
The patent changes the chemical composition parameters by using poly-4-hydroxybutyrate (P4HB) and its copolymers instead of traditional synthetic absorbable materials. This parameter change maintains absorption capability while eliminating inflammatory responses and disease transmission risks associated with xenogenic materials.
Solution Approach 2:
The patent employs composite material strategies by creating copolymers of 4-hydroxybutyrate with 3-hydroxybutyrate or glycolic acid. These composite polymer structures optimize both absorption characteristics and biocompatibility, resolving the contradiction between absorption and harmful effects.
2Reliability
If current absorbable fibers are used, then absorption occurs, but strength retention is short-term leading to complications
Solution Approach 1:
The patent modifies the polymer parameters by controlling molecular weight, crystallinity, and copolymer composition of P4HB. These parameter changes enable tuning of degradation rates to match tissue healing timelines, providing prolonged strength retention (maintaining 50% strength at 4-6 weeks) while ensuring complete absorption within 3-6 months.
Solution Approach 2:
The patent creates dynamically adjustable degradation profiles through copolymerization ratios and molecular weight control. The material transitions from high strength retention in early healing phases to controlled degradation as tissue matures, optimizing both duration of action and absorption timing.
3Strength
If non-absorbable synthetic meshes are used, then long-term strength is maintained, but adhesions and infection risks increase
Solution Approach 1:
The patent changes the material parameter from permanent to temporarily persistent by designing P4HB copolymers with controlled degradation rates. The mesh maintains sufficient strength (50% retention at 4-6 weeks) during the critical healing period, then gradually absorbs to eliminate long-term adhesion and infection risks.
Solution Approach 2:
The patent provides temporary mechanical support that cushions the healing tissue during the vulnerable early postoperative period. The P4HB mesh acts as a sacrificial support structure that degrades after serving its protective function, preventing long-term complications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The absorbable fibers and meshes provide extended mechanical stability, minimize infection risks, and reduce disease transmission, while being absorbed naturally, offering improved handling and biological properties when combined with autologous or xenogenic tissues.
Implementation Method 1
PHAs with degradation rates in vivo of less than one year have been disclosed by U.S. Pat. No. 6,548,569 to Williams et al.
Data Source
AI summary
Absorbable polyester fibers, braids, and surgical meshes with prolonged strength retention have been developed. These devices are preferably derived from biocompatible copolymers or homopolymers of 4-hydroxybutyrate. These devices provide a wider range of in vivo strength retention properties than are currently available, and could offer additional benefits such as anti-adhesion properties, reduced risks of infection or other post-operative problems resulting from absorption and eventual elimination of the device, and competitive cost. The devices may also be particularly suitable for use in pediatric populations where their absorption should not hinder growth, and provide in all patient populations wound healing with long-term mechanical stability. The devices may additionally be combined with autologous, allogenic and/or xenogenic tissues to provide implants with improved mechanical, biological and handling properties.